宾夕法尼亚州马尔文 - 市值7400万美元的临床阶段药物平台公司Annovis Bio Inc. (NYSE: ANVS)今天宣布,美国食品和药物管理局 (FDA)已接受该公司更新的关键第3期阿尔茨海默病 (AD)研究方案。该试验定于今年1月开始。根据 InvestingPro 数据,分析师保持看好态度,目标价在21美元至72美元之间。
TUESDAY, Jan. 7, 2025 (HealthDay News) -- The U.S. Food and Drug Association (FDA) released the first-ever guidelines for ...
Years of research have showed that pulse oximeters yield less accurate readings for people with darker skin tones, and now ...
The FDA will decide later this month whether to approve a novel drug for acute pain that could offer a nonaddictive ...
You don't need a prescription to purchase a test that will tell you whether you're sick with COVID or the flu.
New Jersey-based Abbey Specialty Foods is recalling cheddar cheese products due to fears of listeria contamination. Here’s ...
But consumer advocates say the Food and Drug Administration's new guidance on lead limit in baby food doesn't go far enough.
The FDA's new standards for toxic lead target processed baby foods such as jarred fruits, vegetables, yogurts and dry cereals ...
The Food and Drug Administration has set maximum levels for lead in baby foods like jarred fruits and vegetables, yogurts and ...
The snacks were distributed in the state of New York and have been recalled due to undeclared additives and flavor enhancers.
FDA 授予 CRB-701 快速通道资格,这是一种针对 Nectin-4 的 ADC,可用于治疗 R/R 转移性宫颈癌的成年患者。 CRB-701 是新一代 ADC,具有位点特异性、可裂解的接头;均质一致的药物抗体比为 2,以及针对 ...
近日,美国食品药品监督管理局(FDA)针对BD医疗(Becton, Dickinson and ...